secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001437749-25-032798
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical stockholders approve reverse split, expanded equity plan at annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected; Forvis Mazars ratified as auditor for FY ending Mar 2026.
- Reverse stock split authorized at ratio of 1-for-2 to 1-for-25, board discretion for one year.
- Amended and restated 2023 Equity Incentive Plan approved, increasing authorized shares by 1.9M to ~2.27M.
- Issuance of >20% of outstanding common stock to Lincoln Park Capital Fund, LLC approved.
- Total shares voted 2,871,639 (48% of outstanding) constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/0001437749-25-032798-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/amix20251030_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-032798

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer